Joshua Beilke Email

VP . Sonoma Biotherapeutics

Current Roles

Employees:
157
Revenue:
$30.4M
About
Sonoma Biotherapeutics is inventing the future of living therapies for autoimmune disease — safe, effective treatments as unique as each individual patient. Regulatory T cell therapies that harness a patient’s own immune cells, powerful next generation gene editing techniques and advanced manufacturing and quality assurance processes. Sonoma’s mission is to create a best-in-class regulatory T cell therapy that delivers long-lasting, highly efficacious treatments leading to cures across a spectrum of autoimmune and degenerative diseases.
Sonoma Biotherapeutics Address
201 Haskins Way
San Francisco, CA
United States
Sonoma Biotherapeutics Email

Past Companies

Sonoma BiotherapeuticsVice President
CelgeneDirector: Dept of T Cell Biology and Engineering
CelgeneSenior Principal Scientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.